Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Abraham Rutgers

Showing results (1-10 of 92) with videos related to

Pageof 10
Sort By:
Kidney International|July 15, 2025
Triggering trouble: post-translational modifications may drive myeloperoxidase autoimmunityPeter Heeringa, Abraham Rutgers
Current Opinion in Rheumatology|March 14, 2012
Refractory disease in antineutrophil cytoplasmic antibodies associated vasculitisAbraham Rutgers, Cees G M Kallenberg
Nature Reviews. Rheumatology|December 7, 2011
Vasculitis syndromes: Peripheral neuropathy in AAV--when vasculitis hits a nerveAbraham Rutgers, Cees G M Kallenberg
Autoimmunity Reviews|May 24, 2011
Refractory vasculitisAbraham Rutgers, Cees G M Kallenberg
Kidney International|June 24, 2018
The net effect of ANCA on neutrophil extracellular trap formationPeter Heeringa, Abraham Rutgers, Cees G M Kallenberg
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 9, 2014
Anti-neutrophil cytoplasmic autoantibody pathogenicity revisited: pathogenic versus non-pathogenic anti-neutrophil cytoplasmic autoantibodyJudith Land, Abraham Rutgers, Cees G M Kallenberg
The Pharmacogenomics Journal|July 20, 2020
Gene variants and treatment outcomes in antineutrophil cytoplasmic antibody-associated vasculitisArno C Hessels, Jan Stephan F Sanders, Abraham Rutgers, et al.
Plos One|April 10, 2018
Thiopurine methyltransferase genotype and activity cannot predict outcomes of azathioprine maintenance therapy for antineutrophil cytoplasmic antibody associated vasculitis: A retrospective cohort studyArno C Hessels, Abraham Rutgers, Jan Stephan F Sanders, et al.
Rheumatology (Oxford, England)|May 14, 2024
Comment on: Immune checkpoint inhibitor-mediated polymyalgia rheumatica versus primary polymyalgia rheumatica: comparison of disease characteristics and treatment requirement. ReplyKornelis S M van der Geest, Maria Sandovici, Abraham Rutgers, et al.
Seminars in Respiratory and Critical Care Medicine|June 16, 2011
Pulmonary: renal syndrome with a focus on anti-GBM diseaseJan-Stephan F Sanders, Abraham Rutgers, Coen A Stegeman, et al.
Pageof 10

Showing results (1-10 of 92) with videos related to

Sort By:
Pageof 10
Kidney International|July 15, 2025
Triggering trouble: post-translational modifications may drive myeloperoxidase autoimmunityPeter Heeringa, Abraham Rutgers
Current Opinion in Rheumatology|March 14, 2012
Refractory disease in antineutrophil cytoplasmic antibodies associated vasculitisAbraham Rutgers, Cees G M Kallenberg
Nature Reviews. Rheumatology|December 7, 2011
Vasculitis syndromes: Peripheral neuropathy in AAV--when vasculitis hits a nerveAbraham Rutgers, Cees G M Kallenberg
Autoimmunity Reviews|May 24, 2011
Refractory vasculitisAbraham Rutgers, Cees G M Kallenberg
Kidney International|June 24, 2018
The net effect of ANCA on neutrophil extracellular trap formationPeter Heeringa, Abraham Rutgers, Cees G M Kallenberg
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 9, 2014
Anti-neutrophil cytoplasmic autoantibody pathogenicity revisited: pathogenic versus non-pathogenic anti-neutrophil cytoplasmic autoantibodyJudith Land, Abraham Rutgers, Cees G M Kallenberg
The Pharmacogenomics Journal|July 20, 2020
Gene variants and treatment outcomes in antineutrophil cytoplasmic antibody-associated vasculitisArno C Hessels, Jan Stephan F Sanders, Abraham Rutgers, et al.
Plos One|April 10, 2018
Thiopurine methyltransferase genotype and activity cannot predict outcomes of azathioprine maintenance therapy for antineutrophil cytoplasmic antibody associated vasculitis: A retrospective cohort studyArno C Hessels, Abraham Rutgers, Jan Stephan F Sanders, et al.
Rheumatology (Oxford, England)|May 14, 2024
Comment on: Immune checkpoint inhibitor-mediated polymyalgia rheumatica versus primary polymyalgia rheumatica: comparison of disease characteristics and treatment requirement. ReplyKornelis S M van der Geest, Maria Sandovici, Abraham Rutgers, et al.
Seminars in Respiratory and Critical Care Medicine|June 16, 2011
Pulmonary: renal syndrome with a focus on anti-GBM diseaseJan-Stephan F Sanders, Abraham Rutgers, Coen A Stegeman, et al.
Pageof 10